Previous 10 | Next 10 |
MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints PR Newswire Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM™ Subcutaneous Implantable Defibrillator and EMPOWER™ Leadless Pacemaker ...
2024-05-15 14:20:39 ET Summary This monthly article series shows aggregate industry metrics in the healthcare sector. All healthcare subsectors are overvalued based on my metrics. Pharmaceuticals/biotechnology has the lowest scores in both value and quality. Invesco S&P 50...
Boston Scientific Elects Dr. Cheryl Pegus to Board of Directors PR Newswire MARLBOROUGH, Mass. , May 8, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of Dr. Cheryl Pegus to its board of directors, effective immedi...
2024-05-07 16:35:22 ET Billionaire hedge fund manager Steve Cohen, who is the founder of Point72 Asset Management, has let go of at least seven long-short equity portfolio managers, according to a report by Business Insider.... Read the full article on Seeking Alpha For further ...
2024-05-07 09:01:37 ET Apple ( NASDAQ: AAPL ) recently updated its capital return plan by adding a $110B to its buyback program. According to data highlighted by Mizuho, this massive buyback program is larger than 84% of the stocks that sit inside the S&P 500.... Read ...
2024-05-04 06:15:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Many Wall Street investors keep a close eye on the opinions of major brokerages, such as Citigroup (NYSE: C ). Therefore, today we’ll explore three promising growth...
2024-04-26 07:15:03 ET Barclays analyst issues OVERWEIGHT recommendation for BSX on April 26, 2024 05:04AM ET. The previous analyst recommendation was Overweight. BSX was trading at $73.26 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
2024-04-25 08:15:07 ET Citigroup analyst issues BUY recommendation for BSX on April 25, 2024 06:47AM ET. The previous analyst recommendation was Buy. BSX was trading at $72.91 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...
2024-04-25 07:00:07 ET Lawrence Biegelsen from Wells Fargo issued a price target of $82.00 for BSX on 2024-04-25 05:23:00. The adjusted price target was set to $82.00. At the time of the announcement, BSX was trading at $72.91. The overall price target consensus is at $6...
2024-04-24 18:15:02 ET Deutsche Bank analyst issues HOLD recommendation for BSX on April 24, 2024 04:20PM ET. The previous analyst recommendation was Hold. BSX was trading at $72.91 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
Shares of Boston Scientific Corporation (NYSE: BSX) traded at a new 52-week high today and are currently trading at $78.31. So far today, approximately 1.5M shares have been exchanged, as compared to an average 30-day volume of 5.37M shares. Boston Scientific Corporation develops, manufacture...
2024-07-08 14:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-02 09:15:03 ET Evercore ISI analyst issues OUTPERFORM recommendation for BSX on July 2, 2024 08:01AM ET. The previous analyst recommendation was Outperform. BSX was trading at $76.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...